Corvus Pharmaceuticals Inc (CRVS)

(90% Positive) Corvus Pharmaceuticals Inc (CRVS) Announces Enrollment Update for soquelitinib Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment